Pseudoginsenoside RT1 is primarily studied for its potential therapeutic applications in the field of medicine. It has shown promise in neuroprotection, particularly in reducing neuronal damage caused by ischemic stroke. Research indicates that it may help mitigate brain injury by inhibiting inflammatory responses and oxidative stress, thereby promoting cell survival. Additionally, it has been explored for its anti-cancer properties, as it appears to induce apoptosis in certain cancer cells while sparing normal cells. Pseudoginsenoside RT1 is also being investigated for its role in improving cardiovascular health by enhancing blood flow and reducing myocardial damage. Its potential anti-inflammatory and antioxidant effects make it a candidate for treating various chronic diseases. Further studies are ongoing to fully understand its mechanisms and optimize its clinical applications.